ImClone Ex-Chief Embarks on New Biotech Venture
Sunday, October 31, 2010 - 22:30
in Biology & Nature
Not yet two years after serving time for insider trading, Samuel Waksal is again making deals.
Updated by artificial intelligence Thu, 13 Mar 2025, 3:35:01 UTC Learn more
- Tell your friends
- Get science news via